{"disease":{"id":"advanced-primary-liver-cancer","name":"advanced primary liver cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02072356","title":"Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03092895","title":"A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":true},{"nct_id":"NCT03166553","title":"Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"BeiJing Yijiayi Medicine Techonoloy Co., Ltd.","has_results":false},{"nct_id":"NCT03167775","title":"Clinical Trial of Elemene Injection/Elemene Oral Emulusion in Combination With the Best Supportive Treatment in the Treatment of Advanced Primary Liver Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"BeiJing Yijiayi Medicine Techonoloy Co., Ltd.","has_results":false},{"nct_id":"NCT01666756","title":"Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05411757","title":"IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Shandong Public Health Clinical Center","has_results":false},{"nct_id":"NCT02119065","title":"Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"University of Cincinnati","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}